Medicare Enrolled
Dr. Ravi Patel, MD
Hematology & Oncology · Stuart, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Ravi Patel is a hematology & oncology in Stuart, FL, with 12 years in practice. Based on federal Medicare data, Dr. Patel performed 111,435 Medicare services across 3,902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $22,381 from 89 pharmaceutical and/or device companies across 831 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 6% volume in FL$ $22,381 industry payments
Medicare Practice Summary
Medicare Utilization ↗111,435
Medicare services
Top 6% in FL for hematology & oncology
3,902
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,286 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 27,750 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 17,800 | $43 | $106 |
| Anti-nausea injection (fosaprepitant) | 15,900 | $0 | $1 |
| Paclitaxel chemotherapy injection | 10,628 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 9,780 | $19 | $38 |
| Iron infusion (Monoferric) | 6,200 | $17 | $51 |
| Dexamethasone injection (steroid) | 5,002 | $0 | $2 |
| Complete blood count (CBC) with differential | 2,257 | $8 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,180 | $1 | $2 |
| Comprehensive metabolic blood panel | 1,593 | $10 | $40 |
| Contrast dye for imaging (iodine-based) | 1,500 | $0 | $0 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 1,467 | $65 | $173 |
| Epoetin alfa injection (Retacrit) for anemia | 1,400 | $6 | $22 |
| Office visit, established patient (30-39 min) | 1,091 | $101 | $175 |
| Injection, carboplatin, 50 mg | 499 | $2 | $15 |
| Administration of chemotherapy into vein, 1 hour or less | 478 | $107 | $330 |
| Infusion, normal saline solution, 250 cc | 472 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 451 | $24 | $76 |
| Ferritin level test (iron stores) | 431 | $13 | $27 |
| Vitamin B-12 level test | 326 | $15 | $30 |
| Folic acid level test | 311 | $14 | $29 |
| Injection, magnesium sulfate, per 500 mg | 300 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 244 | $52 | $150 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 238 | $59 | $135 |
| Administration of additional new drug or substance into vein, 1 hour or less | 227 | $53 | $165 |
| Hospital follow-up visit, high complexity | 221 | $99 | $185 |
| Thyroid stimulating hormone (TSH) test | 213 | $16 | $34 |
| Injection of additional new drug or substance into vein | 192 | $13 | $56 |
| Administration of chemotherapy into vein, each additional hour | 179 | $23 | $78 |
| Drug injection, under skin or into muscle | 166 | $11 | $45 |
| Injection, diphenhydramine hcl, up to 50 mg | 145 | $1 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 139 | $27 | $125 |
| Initial hospital admission, high complexity | 139 | $144 | $330 |
| Office visit, established patient, complex (40-54 min) | 136 | $144 | $251 |
| Lactate dehydrogenase (enzyme) level | 134 | $6 | $15 |
| PSA test (prostate cancer screening) | 120 | $18 | $37 |
| Magnesium level test | 118 | $7 | $15 |
| Office visit, established patient (20-29 min) | 99 | $71 | $111 |
| New patient office visit, complex (60-74 min) | 84 | $176 | $364 |
| Telephone medical discussion with physician, 11-20 minutes | 78 | $50 | $105 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 77 | $16 | $50 |
| Hospital follow-up visit, moderate complexity | 73 | $66 | $130 |
| Carcinoembryonic antigen (cea) protein level | 70 | $19 | $38 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 70 | $16 | $48 |
| Telephone medical discussion with physician, 5-10 minutes | 67 | $28 | $100 |
| Irrigation of implanted venous access drug delivery device | 58 | $19 | $54 |
| Blood draw (venipuncture) | 55 | $8 | $15 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 50 | $364 | $1,111 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 43 | $20 | $42 |
| New patient office visit (45-59 min) | 37 | $127 | $300 |
| Phosphate level test | 34 | $5 | $11 |
| Infusion into a vein for hydration, each additional hour | 32 | $11 | $40 |
| Free thyroxine (T4) test | 24 | $9 | $18 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $28 | $68 |
| CT scan of abdomen and pelvis with contrast | 13 | $189 | $651 |
| Ct scan of chest with contrast | 12 | $48 | $355 |
| Initial hospital admission, moderate complexity | 12 | $109 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.8% high complexity
59.7% medium
8.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,381
Total received (2018-2024)
Avg $3,197/year across 7 years
Top 24% in FL for hematology & oncology
89
Companies
831
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,155 (76.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,226 (23.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,760
2023$4,872
2022$8,092
2021$2,912
2020$814
2019$730
2018$202
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Laboratory Corporation of America Holdings
$4,095
AstraZeneca Pharmaceuticals LP
$1,776
Janssen Biotech, Inc.
$1,389
PFIZER INC.
$1,274
Celgene Corporation
$913
GENZYME CORPORATION
$804
Genentech USA, Inc.
$751
Astellas Pharma US Inc
$721
Incyte Corporation
$615
Amgen Inc.
$607
E.R. Squibb & Sons, L.L.C.
$579
Novartis Pharmaceuticals Corporation
$561
Lilly USA, LLC
$516
Daiichi Sankyo Inc.
$471
GlaxoSmithKline, LLC.
$432
Merck Sharp & Dohme Corporation
$380
Seagen Inc.
$364
Regeneron Healthcare Solutions, Inc.
$358
Exelixis Inc.
$323
Ipsen Biopharmaceuticals, Inc
$313
Merck Sharp & Dohme LLC
$305
Karyopharm Therapeutics Inc.
$267
JAZZ PHARMACEUTICALS INC.
$224
Eisai Inc.
$212
Pharmacyclics LLC, An AbbVie Company
$210
ABBVIE INC.
$191
Coherus Biosciences Inc.
$189
Bayer HealthCare Pharmaceuticals Inc.
$179
Medtronic, Inc.
$175
SERVIER PHARMACEUTICALS LLC
$165
Sun Pharmaceutical Industries Inc.
$164
ARRAY BIOPHARMA INC
$148
Alexion Pharmaceuticals, Inc.
$145
ADC Therapeutics America, Inc.
$138
Bayer Healthcare Pharmaceuticals Inc.
$136
Jazz Pharmaceuticals Inc.
$113
Mirati Therapeutics, Inc.
$109
Takeda Pharmaceuticals U.S.A., Inc.
$102
Pharmacyclics LLC, an AbbVie Company
$101
AVEO Pharmaceuticals, Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$86
Pharmacosmos Therapeutics Inc.
$85
PharmaEssentia USA Corporation
$78
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$78
TerSera Therapeutics LLC
$71
Tempus AI, Inc
$69
Sobi, Inc
$68
EMD Serono, Inc.
$62
Myriad Genetic Laboratories, Inc.
$62
RECORDATI_RARE_DISEASES_INC.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Agios Pharmaceuticals, Inc.
$52
Deciphera Pharmaceuticals Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$50
Taiho Oncology, Inc.
$49
BeiGene USA, Inc.
$44
SOBI, INC
$43
Acrotech Biopharma Inc.
$42
Cumberland Pharmaceuticals, Inc.
$38
ACCORD HEALTHCARE, INC.
$37
Tolmar, Inc.
$30
Sumitomo Pharma America, Inc.
$27
Kite Pharma, Inc.
$27
Novocure Inc.
$26
Biocon Biologics Inc
$25
Organon Llc
$24
Foundation Medicine, Inc.
$23
Mylan Institutional Inc.
$23
CTI BioPharma Corp.
$22
Acceleron Pharma, Inc.
$22
Seattle Genetics, Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
Genmab U.S., Inc.
$21
Blueprint Medicines Corporation
$21
Fennec Pharmaceuticals, Inc.
$20
EUSA Pharma (US) LLC
$20
G1 Therapeutics, Inc.
$20
Amneal Pharmaceuticals LLC
$19
AbbVie Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Blue Earth Diagnostics Limited
$18
Teva Pharmaceuticals USA, Inc.
$18
Stemline Therapeutics Inc.
$17
Clovis Oncology, Inc.
$15
ImmunoGen, Inc.
$15
Kyowa Kirin, Inc.
$15
Dova Pharmaceuticals
$12
Acrotech Biopharma LLC
$12
Myovant Sciences Inc.
$11
Top 3 companies account for 32.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AVASTIN · AYVAKIT · Aliqopa · Aranesp · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARBAGLU · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Enhertu · Epkinly · FOTIVDA · Fulphila · GILOTRIF · GIVLAARI · Hulio · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · LifeVest · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Odomzo · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PGDX ELIO TISSUE COMPLETE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Prolaris · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYZNEUTA · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SOMATULINE DEPOT · SYLVANT · Somatuline Depot · Sylvant · TABRECTA · TAGRISSO · TALVEY · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $20 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
18
Per 100K population
11.2
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Patel performed 27,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $22,381 from 89 companies across 831 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncologys in Stuart?
Dr. Patel's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Stuart
Browse hematology & oncologys in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Laboratory Corporation of America Holdings Payments to Doctors
See all physicians who received payments from Laboratory Corporation of America Holdings.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology